Ultralife(US:ULBI)2025-11-18 14:32Financial Data and Key Metrics Changes - Consolidated revenues for Q3 2025 totaled $43.4 million, up from $35.7 million in Q3 2024, representing a year-over-year growth [9] - Operating loss was $1 million, including a one-time adjustment of $1.1 million, resulting in a GAAP net loss of $0.07 per share compared to a net income of $0.3 million or $0.02 per share in the previous year [5][15] - Consolidated gross profit increased to $9.6 million, a 10.8% increase from $8.7 million in Q3 2024, but gross margin declined to 22.2% from 24.3% [11][12] Business Line Data and Key Metrics Changes - Battery and energy product segment revenues were $39.9 million, up from $32.5 million year-over-year, with a gross profit of $8.8 million [9][12] - Communication systems segment revenues increased by 8.2% to $3.4 million, with gross profit rising to $0.8 million [10][12] - Government defense sales increased by 19%, while commercial sales decreased by 5.7%, primarily due to declines in oil and gas and medical battery sales [10] Market Data and Key Metrics Changes - The sales split between commercial and government defense for the battery business was 70/30, consistent with the previous year's 69/31 [10] - Domestic-to-international sales split shifted to 72/28 from 56/44, reflecting increased domestic shipments of government defense products [10] - Total backlog at the end of Q3 was $90.1 million, a 6.5% increase from $84.5 million at the end of Q2 [11] Company Strategy and Development Direction - The company is focusing on diversification through M&A and new product development to stabilize and improve profitability [6][8] - A company-wide rebranding initiative is underway to unify the Ultralife brand and enhance market identity [7][18] - The closure of the Calgary facility is expected to yield annual savings of approximately $0.8 million throughout 2026 [12][16] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges with gross margins due to supply chain quality issues but remains optimistic about future growth opportunities [5][25] - The completion of the Electric Chem transition is expected to enhance vertical integration and broaden market opportunities [17][26] - The company is intensifying efforts to improve gross margins through pricing strategies and lean productivity projects [18][19] Other Important Information - Operating expenses increased by 29.4% year-over-year to $10.6 million, influenced by the inclusion of Electric Chem and one-time costs [12] - The company has reduced debt principal by $4.1 million in the first nine months of 2025, exceeding the required amortization [16] Q&A Session Summary - No questions were raised during the Q&A session, and the call concluded with closing remarks from management [27][28]